NCT05613946 - Contrast-Enhanced Ultrasound and Shear Wave Elastography for the Treatment of Lymphedema | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 15, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

Lymphedema Arm

Interventions

DRUG

Lumason

Ultrasound microbubble contrast agent intradermal 0.2-0.3 cc of microbubble suspension per injection, 10-12 total injections per upper extremity

DRUG

Optison

Ultrasound microbubble contrast agent intradermal 0.2-0.3 cc of microbubble suspension per injection, 10-12 total injections per upper extremity

DRUG

Definity

Ultrasound microbubble contrast agent intradermal 0.2-0.3 cc of microbubble suspension per injection, 10-12 total injections per upper extremity

Trial Locations (1)

Mayo Clinic in Rochester, Rochester